Skip to main content

Articles

Page 1 of 19

  1. Substance use among adolescents poses significant risks to their health, wellbeing, and development, particularly in low- and middle-income countries, including Ghana. However, little is known about the outlet...

    Authors: Sylvester Kyei-Gyamfi, Frank Kyei-Arthur, Nurudeen Alhassan, Martin Wiredu Agyekum, Prince Boamah Abrah and Nuworza Kugbey
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:17
  2. Gay, bisexual, and other men who have sex with men (GBM) report high rates of problematic alcohol use, anxiety, and depression. This may, in part, be due to stressors related to their sexual identity (i.e., mi...

    Authors: Adhm Zahran, Sarah S. Dermody, Graham W. Berlin, Paolo A. Palma, Shayna Skakoon-Sparling, Syed W. Noor, Nathan J. Lachowsky, Daniel Grace, Joseph Cox, David M. Moore, Gilles Lambert, Terri H. Zhang, Milada Dvorakova, Jody Jollimore, Allan Lal and Trevor A. Hart
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:16
  3. Vaccination is one of the most effective ways to manage infectious disease epidemics such as Covid-19. However, the low rates of vaccination in populations at risk including people using illicit substances, hi...

    Authors: Salah Eddin Karimi, Sina Amadi, Zahra Rampisheh, Batool Tayefi, Neda Soleimanvandiazar, Peter Higgs, Arash Tehrani-Banihashemi, Ahmad Hajebi, Marzieh Nojomi and Gelavizh Karimijavan
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:15
  4. People with opioid use disorder (OUD) are high-risk for short-term mortality and morbidity. Emergency department (ED) interventions can reduce those risks, but benefits wane without ongoing community follow-up.

    Authors: Rukaiyah Lakkadghatwala, Daniel Lane, Frank Scheuermeyer, Jesse Hilburt, Jane Buxton, Cheyenne Johnson, Seonaid Nolan, Christy Sutherland, Jessica Moe, Raoul Daoust, Kathryn Dong, Jim Christenson, Isabelle Miles, Aaron Orkin, Madelyn Whyte and Andrew Kestler
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:14
  5. Substance abuse, particularly tobacco smoking, is a significant global public health concern. Efforts have been made to reduce smoking prevalence and promote cessation, but challenges, such as nicotine addicti...

    Authors: Waleed M. Sweileh
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:13
  6. People with opioid use disorder (OUD) are frequently in contact with the court system and have markedly higher rates of fatal opioid overdose. Opioid intervention courts (OIC) were developed to address increas...

    Authors: Megan A. O’Grady, Katherine S. Elkington, Gail Robson, Ikenna Y. Achebe, Arthur Robin Williams, Alwyn T. Cohall, Renee Cohall, Monica Christofferson, Alejandra Garcia, Kelly S. Ramsey, Pat Lincourt and Susan Tross
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:12
  7. Marketing and sales of e-cigarettes are unregulated in Malaysia. We analyzed content displayed on e-cigarette retailer websites to identify marketing claims, promotional strategies, and product details in the ...

    Authors: Sameeha Misriya Shroff and Chandrashekhar T Sreeramareddy
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:11
  8. User perspectives and involvement are crucial for improving substance use treatment service provision. First-hand accounts provide rich perspectives on how users experience change within therapeutic approaches...

    Authors: Claire M. Ghetti, Steinar Hjelmbrekke, Katharina Morken, Therese Dahl and Brynjulf Stige
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:10
  9. Crack heroin is a novel opiate derivative with highly addictive properties and unfamiliar health consequences. It causes a variety of brain dysfunctions that are mediated by neurochemical alterations and abnor...

    Authors: Enam Alhagh Charkhat Gorgich, Mohammad Gol Rigi, Hamed Fanaei, Houman Parsaei and Abdolhakim Ghanbarzehi
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:9
  10. Opioid use remains a major public health issue, especially among young adults. Despite investment in harm reduction and supply-side strategies such as reducing overprescribing and safe medication disposal, little...

    Authors: Parissa J. Ballard, Taylor J. Arnold, Elena M. Vidrascu, Guadalupe C. Hernandez, Emily Ozer, Mark Wolfson, Rebekah Lassiter, Himani Nayyar and Stephanie S. Daniel
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:8
  11. Drug checking services (DCS) provide harm reduction support and advice to individuals based on chemical analysis of submitted substances of concern. Whilst there are currently no DCS in Scotland, community-bas...

    Authors: Danilo Falzon, Hannah Carver, Wendy Masterton, Bruce Wallace, Harry Sumnall, Fiona Measham, Vicki Craik, Rosalind Gittins, Elizabeth V. Aston, Kira Watson, Carole Hunter, Saket Priyadarshi and Tessa Parkes
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:7
  12. With substance use rates increasing in Sub-Saharan Africa (SSA), an understanding of the accessibility and effectiveness of rehabilitative services for people who use alcohol and other drugs (AOD) is critical ...

    Authors: Samuel Janson, Lily Nyenga, Haneefa Saleem, Larissa Jennings Mayo-Wilson, Stella E. Mushy, Masunga K. Iseselo, Jenna van Draanen, Joseph Tucker, Mecca McPherson and Donaldson F. Conserve
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:6
  13. This study explores how Special Interest Meetings (SIMs), also called topic-specific meetings (e.g., meetings for young people), support recovery in 12-Step fellowships for Special Populations like young peopl...

    Authors: Frankco Harris
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:5
  14. The 2010 release of an abuse deterrent formulation (ADF) of OxyContin, a brand name prescription opioid, has been cited as a major driver for the reduction in prescription drug misuse and the associated increa...

    Authors: Eric W. Lundstrom, Zheng Dai, Caroline P. Groth, Brian Hendricks, Erin L. Winstanley, Marie Abate and Gordon S. Smith
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:4
  15. Previous research has demonstrated that remissions from alcohol use disorders can occur without accessing treatment. The current study explored the prevalence of such untreated remissions in the UK and further...

    Authors: John A. Cunningham, Christina Schell, Hollie Walker and Alexandra Godinho
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:3
  16. Lesbian, gay, bisexual, transgender, queer, and other LGBTQ populations (LGBTQ+; e.g., asexual individuals) have higher rates of substance use (SU) and disorders (SUD) compared to heterosexual and cisgender po...

    Authors: Margaret M. Paschen-Wolff, Avery DeSousa, Emily Allen Paine, Tonda L. Hughes and Aimee N.C. Campbell
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:2
  17. Across different types of oral Opioid Agonist Treatment for people with Opioid Use Disorder, receiving a dose that meets their needs is associated with better outcomes. Evidence also shows patients are more li...

    Authors: Scott Beaumont, Tianna Magel, Scott MacDonald, Scott Harrison, Martin Schechter and Eugenia Oviedo-Joekes
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:1
  18. Ontario has one of the highest rates of substance-related harms in Canada. Residential treatment programs in the province provide a variety of in-house treatment services to support the needs of individuals wi...

    Authors: Farihah Ali, Justine Law, Cayley Russell, Nikki Bozinoff and Brian Rush
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:73
  19. Drug injection is a major health-related problem worldwide. Injection cessation and relapse to injection could significantly alter the risk of HIV and hepatitis C virus (HCV) among people who inject drugs (PWI...

    Authors: Soheil Mehmandoost, Ali Mirzazadeh, Mohammad Karamouzian, Mehrdad Khezri, Heidar Sharafi, Armita Shahesmaeili, Saiedeh Haji Maghsoudi, Nima Ghalekhani, Fatemeh Tavakoli, Maliheh Sadat Bazrafshani, Mostafa Shokoohi, Niloufar Aghaali, Ali Akbar Haghdoost and Hamid Sharifi
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:72
  20. As a subfield of prevention science, substance use prevention researchers and professionals are increasingly focused on translating research into practice, developing the workforce of prevention specialists, a...

    Authors: Parissa J. Ballard, Heather K. Kennedy, Jessica J. Collura, Elena Vidrascu and Chelsey Garcia Torres
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:71
  21. Youth mortality from drugs is worryingly increasing in Europe. Little is so far known about what substance use services are available to young people. An out-of-home care placement is often used but does not s...

    Authors: Janika Kosonen and Katja Kuusisto
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:70
  22. Substance use (SU) and substance use disorders (SUDs) have been recently documented among forcibly displaced populations as a coping mechanism to migration and postmigration stressors. Although the literature ...

    Authors: Ebtesam A. Saleh, Felix Klapprott, Andreas Heinz and Ulrike Kluge
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:69
  23. The concept of recovery has increasingly become an organizing paradigm in the addiction field in the past 20 years, but definitions of the term vary amongst interested groups (e.g. researchers, clinicians, pol...

    Authors: Ed Day, Ifigeneia Manitsa, Amanda Farley and John F. Kelly
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:68
  24. Anabolic–androgenic steroids (AAS) mimic the effects of testosterone and may include testosterone itself; they are used for body enhancement within the general population. AAS use has been linked with increase...

    Authors: Bonnie Grant, Joseph Kean, Naim Vali, John Campbell, Lorraine Maden, Prun Bijral, Waljit S. Dhillo, James McVeigh, Richard Quinton and Channa N. Jayasena
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:66
  25. The Baltic countries–Lithuania, Latvia and Estonia–are characterized by a high rate of fully alcohol-attributable mortality, compared with Poland. Alcohol control policy measures implemented since 2001 in the ...

    Authors: Ričardas Radišauskas, Mindaugas Štelemėkas, Janina Petkevičienė, Justina Trišauskė, Tadas Telksnys, Laura Miščikienė, Inese Gobina, Relika Stoppel, Rainer Reile, Kinga Janik-Koncewicz, Witold Zatonski, Shannon Lange, Alexander Tran, Jürgen Rehm and Huan Jiang
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:65
  26. Opioid-related overdose deaths remain a common cause of death in many settings, and opioid maintenance treatment is evidence-based for the treatment of opioid use disorders. However, access to such treatment v...

    Authors: Anders Håkansson, Sahar Janfada-Baloo and Jonas Berge
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:64
  27. Substance use disorders (SUD) pose a significant public health problem in Uganda. Studies indicate that integrating mental health services into Primary Health Care can play a crucial role in alleviating the im...

    Authors: Harriet Aber-Odonga, Fred Nuwaha, Esther Kisaakye, Ingunn Marie S. Engebretsen and Juliet Ndimwibo Babirye
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:63
  28. Integrated youth services (IYS) are vital to addressing the needs of youth who use substances. Evidence on the characteristics of youths accessing these services and the types of services accessed have been li...

    Authors: Nikki Ow, Kirsten Marchand, Guiping Liu, Emilie Mallia, Steve Mathias, Jason Sutherland and Skye Pamela Barbic
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:62
  29. Alcohol consumption during the pregnancy period is high despite the well-established evidence of its harmful effects on pregnancy and infant development. Early identification and behavioral modification are of...

    Authors: Tilahun Bete, Henock Asfaw, Kabtamu Nigussie, Addisu Alemu, Addis Eyeberu Gebrie, Deribe Bekele Dechasa, Kabtamu Gemechu, Mesay Arkew, Beniam Daniel, Habtam Gelaye, Asrat Wolde, Mulat Awoke Kassa and Tamrat Anbesaw
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:61
  30. Digital interventions readily permit data capture of participant engagement with them. If future interventions are intended to be more interactive, tailored, or a useful resource offered to users, it may be va...

    Authors: Elizabeth S. Collier, Jenny Blomqvist, Joel Crawford, Jim McCambridge and Marcus Bendtsen
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:60
  31. Opioid use is a major public health concern across the globe. Opioid use and subsequent access to care is often shaped by co-occurring issues faced by people using opioids, such as deprivation, mental ill-heal...

    Authors: Emma A Adams, Justin C Yang, Amy O’Donnell, Sarah Minot, David Osborn and James B Kirkbride
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:59
  32. Substance use is a leading cause of preventable morbidity and mortality worldwide. Population-wide screening for problematic substance use in primary health care may mitigate the serious health and socio-econo...

    Authors: Dvora Shmulewitz, Roi Eliashar, Maor Daniel Levitin and Shaul Lev-Ran
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:58
  33. The overdose crisis continues across Canada which calls for novel harm reduction strategies. Previous research indicates that a majority of eHealth solutions are cost-effective however current literature on th...

    Authors: William Rioux, Benjamin Enns, Jennifer Jackson, Hena Quereshi, Mike Irvine and S. Monty Ghosh
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:57
  34. The COVID-19 pandemic led to an unprecedented relaxation of restrictions on take-home doses in opioid agonist treatment (OAT). We conducted a mixed methods systematic review to explore the impact of these chan...

    Authors: Alison Adams, Sarin Blawatt, Tianna Magel, Scott MacDonald, Julie Lajeunesse, Scott Harrison, David Byres, Martin T. Schechter and Eugenia Oviedo-Joekes
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:56
  35. The US federal regulations allow pharmacy administration and dispensing of methadone for opioid use disorder (PADMOUD) to increase the capability of opioid treatment programs (OTPs) in providing methadone main...

    Authors: Li-Tzy Wu, Paolo Mannelli, William S. John, Alyssa Anderson and Robert P. Schwartz
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:55
  36. In the US and Israel, non-medical (‘recreational’) cannabis use is illegal at the national level; however, use rates are high and decriminalization and legalization is spreading. Thus, theory-based interventio...

    Authors: Yuxian Cui, Cassidy R. LoParco, Yael Bar-Zeev, Zongshuan Duan, Hagai Levine, Lorien C. Abroms, Yan Wang, Amal Khayat and Carla J. Berg
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:54
  37. The shift from prescription to illicit drugs involved in drug poisoning deaths raises questions about the current utility of prescription drug monitoring program (PDMP) data to inform drug poisoning (overdose)...

    Authors: Patricia R. Freeman, Jana McAninch, Nabarun Dasgupta, Douglas R. Oyler, Krassimir Slavov, Candice Collins, Sarah Hargrove, Edward Freeman, Dustin Miracle and Svetla Slavova
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:53
  38. Recovery, a primary goal of addiction treatment, goes beyond abstinence. Incorporating broad domains with key elements that vary across individuals, recovery is a difficult concept to measure. Most addiction-r...

    Authors: Elisabeth Okrant, Sharon Reif and Constance M. Horgan
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:52
  39. Nicotine dependence, factors associated with dependence, and self-reported side effects among people who use e-cigarettes are scarce in developing countries.

    Authors: Chandrashekhar T. Sreeramareddy, Sameeha Misriya Shroff and Shilpa Gunjal
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:51
  40. Electronic cigarette use has surged internationally in recent years, with numerous countries noting an uptick in users. Despite this, the portrayal of e-cigarette usage in African news remains unclear.

    Authors: Chimwemwe Ngoma and Yusuff Adebayo Adebisi
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:50
  41. This study examines the functions and purposes of the International Center for Alcohol Policies (ICAP) book series, published by Routledge between 1998 and 2010. The books were authored by invited academics, I...

    Authors: Andrew Bartlett and Jim McCambridge
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:49
  42. Authors: Magdalena Ydreborg, Emil Lundström, Rosanna Kolleby, Sofia Lexén, Elena Pizarro, Jessica Lindgren, Rune Wejstål and Simon B. Larsson
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:48

    The original article was published in Substance Abuse Treatment, Prevention, and Policy 2023 18:17

  43. Physical diseases represent a significant burden for opioid agonist treatment (OAT) patients. This study described physical morbidity in two national cohorts of OAT patients focusing on gender differences.

    Authors: Gabriela Rolová, Desiree Eide, Roman Gabrhelík, Ingvild Odsbu, Thomas Clausen and Svetlana Skurtveit
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:47
  44. Data on driving under the influence of alcohol (DUIA) are not always available, accurate, or reliable, making it difficult to study the effects of alcohol policies on road traffic outcomes. The objectives of o...

    Authors: Pablo Martínez, Junon Joseph and José Ignacio Nazif-Munoz
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:46
  45. While person-centered care (PCC) includes multiple domains, residential substance use disorder (SUD) treatment clients may value certain domains over others. We sought to identify the PCC domains most valued b...

    Authors: Barbara Andraka-Christou, Danielle N. Atkins, Morgan C. Shields, Olivia K. Golan, Rachel Totaram, Kendall Cortelyou, Glenn W. Lambie and Olena Mazurenko
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:45
  46. Substance use constitutes a major public health issue especially among adolescents as it has associated adverse behavioural, health, social and economic outcomes. However, there is a paucity of comprehensive e...

    Authors: Nuworza Kugbey
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:44
  47. Encephalopathy can occur from a non-fatal toxic drug event (overdose) which results in a partial or complete loss of oxygen to the brain, or due to long-term substance use issues. It can be categorized as a no...

    Authors: Chloé G. Xavier, Margot Kuo, Roshni Desai, Heather Palis, Gemma Regan, Bin Zhao, Jessica Moe, Frank X. Scheuermeyer, Wen Qi Gan, Soha Sabeti, Louise Meilleur, Jane A. Buxton and Amanda K. Slaunwhite
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:42
  48. The high rate of treatment failure is a common problem in the treatment of methamphetamine use. Therefore, the aim of this research is to identify the most common causes of relapse in methamphetamine users.

    Authors: Faezeh Kaviyani, Mohammad Khorrami, Hamid Heydari and Malihe Namvar
    Citation: Substance Abuse Treatment, Prevention, and Policy 2023 18:41

Annual Journal Metrics

  • 2022 Citation Impact
    3.3 - 2-year Impact Factor
    3.5 - 5-year Impact Factor
    1.309 - SNIP (Source Normalized Impact per Paper)
    0.899 - SJR (SCImago Journal Rank)

    2022 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    116 days submission to accept (Median)

    2022 Usage 
    1,214,034 downloads
    2,803 Altmetric mentions